Gsk 주식 가격. GSK - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

가격

1,359.00

매수가

1,356.00

매도가

1,356.50

거래량

10,275,835

1,356.00 일간 변동폭 1,373.50

1,282.50 52주 범위 1,820.00

market_cap

56.332B

전일 종가

1,348.50

개장가

1,366.00

최근 거래 시간

742066

1364.0747

(O)

마지막 거래 시간

재정 규모

140,252,981p

VWAP

1,364.8816

평균 볼륨(3m)

8,009,927

발행 주식

4,145,119,334

배당수익률

4.42%

주가수익률

11.41

주당순이익(EPS)

1.19

매출

30.33B

순이익

4.93B

섹터

Pharmaceutical Preparations

산업

Pharmaceutical Preparations

웹사이트

www.gsk.com

본부

London, Gbr

설립됨

Gsk Plc is listed in the Pharmaceutical Preparations sector of the 런던증권거래소 with ticker GSK. The last closing price for Gsk was 1,348.50p. Over the last year, Gsk shares have traded in a share price range of 1,282.50p to 1,820.00p.

Gsk currently has 4,145,119,334 shares in issue. The market capitalisation of Gsk is £55.90 billion. Gsk has a price to earnings ratio (PE ratio) of 11.41.

GSK PLC Director/PDMR Shareholding

GSK PLC 16 January 2025 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name David Redfern b) Position/status President...

GSK PLC Director/PDMR Shareholding

GSK PLC 15 January 2025 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief...

GSK PLC Director/PDMR Shareholding

GSK PLC 14 January 2025 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief...

GSK PLC Director/PDMR Shareholding

GSK PLC 13 January 2025 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief...

GSK to buy precision therapeutics firm IDRx for up to USD1.15 billion

GSK PLC on Monday said it has agreed to acquire Boston, Massachusetts-based IDRx Inc in a deal that will add to its " ...

GSK PLC GSK enters agreement to acquire IDRx, Inc.

GSK PLC 13 January 2025 Issued: 13 January 2025, London UK GSK enters agreement to acquire IDRx, Inc. · Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor...

GSK awaits FDA review of new shingles vaccine presentation

GSK PLC on Friday reported the US Food & Drug Administration has accepted its Shingrix vaccine syringe for review. ...

GSK PLC Shingrix fully liquid accepted for US FDA review

GSK PLC 10 January 2025 Issued: 10 January 2025, London UK GSK's Shingrix new prefilled syringe presentation accepted for review by US FDA · If approved, the new presentation will...

GSK PLC Director/PDMR Shareholding

GSK PLC 16 January 2025 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name David Redfern b) Position/status President...

GSK PLC Director/PDMR Shareholding

GSK PLC 15 January 2025 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief...

GSK PLC Director/PDMR Shareholding

GSK PLC 14 January 2025 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief...

GSK PLC Director/PDMR Shareholding

GSK PLC 13 January 2025 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief...

GSK to buy precision therapeutics firm IDRx for up to USD1.15 billion

GSK PLC on Monday said it has agreed to acquire Boston, Massachusetts-based IDRx Inc in a deal that will add to its " ...

GSK PLC GSK enters agreement to acquire IDRx, Inc.

GSK PLC 13 January 2025 Issued: 13 January 2025, London UK GSK enters agreement to acquire IDRx, Inc. · Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor...

GSK awaits FDA review of new shingles vaccine presentation

GSK PLC on Friday reported the US Food & Drug Administration has accepted its Shingrix vaccine syringe for review. ...

GSK PLC Shingrix fully liquid accepted for US FDA review

GSK PLC 10 January 2025 Issued: 10 January 2025, London UK GSK's Shingrix new prefilled syringe presentation accepted for review by US FDA · If approved, the new presentation will...

GSK hails FDA breakthrough therapy designation for bone cancer drug

GSK PLC on Tuesday said the US Food & Drug Administration has granted a breakthrough therapy designation to its treat ...

GSK PLC GSK ADC gets FDA breakthrough therapy designation

GSK PLC 07 January 2025 Issued: 7 January 2025, London UK GSK's B7-H3-targeted antibody-drug conjugate, GSK'227, receives US FDA Breakthrough Therapy Designation in late-line relapsed or...

GSK treatment approved for adults with sinus condition in China

GSK PLC on Friday reported that its Nucala treatment has been approved in China to treat long-term sufferers of a sin ...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	14	1.04089219331	1345	1373.5	1289	6180739	1326.26082012	DE
4	50.5	3.85938097058	1308.5	1373.5	1289	5776952	1337.24995952	DE
12	-89	-6.14640883978	1448	1462	1282.5	8009927	1354.26930648	DE
26	-136.5	-9.12738214644	1495.5	1678	1282.5	7529456	1456.79569185	DE
52	-210.8	-13.4284622245	1569.8	1820	1282.5	7786956	1550.9349757	DE
156	-361.4	-21.006742618	1720.4	1824.4	1282.5	8610157	1522.74202702	DE
260	-452.4	-24.9751573369	1811.4	1857	1190.8	8791973	1502.08667503	DE

GSK - Frequently Asked Questions (FAQ)

What is the current Gsk share price?

The current share price of Gsk is 1,359.00p

How many Gsk shares are in issue?

Gsk has 4,145,119,334 shares in issue

What is the market cap of Gsk?

The market capitalisation of Gsk is GBP 55.9B

What is the 1 year trading range for Gsk share price?

Gsk has traded in the range of 1,282.50p to 1,820.00p during the past year

What is the PE ratio of Gsk?

The price to earnings ratio of Gsk is 11.41

What is the cash to sales ratio of Gsk?

The cash to sales ratio of Gsk is 1.85

What is the reporting currency for Gsk?

Gsk reports financial results in GBP

What is the latest annual turnover for Gsk?

The latest annual turnover of Gsk is GBP 30.33B

What is the latest annual profit for Gsk?

The latest annual profit of Gsk is GBP 4.93B

What is the registered address of Gsk?

The registered address for Gsk is 79 NEW OXFORD STREET, LONDON, WC1A 1DG

What is the Gsk website address?

The website address for Gsk is www.gsk.com

Which industry sector does Gsk operate in?

Gsk operates in the PHARMACEUTICAL PREPARATIONS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
QBTQuantum Blockchain Technologies Plc	1.625p (124.14%)	460.21M
PPSProton Motor Power Systems Plc	0.425p (112.50%)	3.73M
IMMImmupharma Plc	3.60p (37.14%)	9.73M
MIRIMirriad Advertising Plc	0.20p (25.00%)	51M
BMVBluebird Mining Ventures Ltd	0.75p (25.00%)	30.39M
IGRIg Design Group Plc	59.00p (-58.60%)	9.76M
CELCeladon Pharmaceuticals Plc	22.00p (-31.25%)	1.23M
DGI9Digital 9 Infrastructure Plc	14.90p (-25.87%)	14.49M
PREMPremier African Minerals Limited	0.0275p (-23.61%)	2.06B
NOGNostrum Oil & Gas Plc	2.60p (-20.12%)	30.22k
PREMPremier African Minerals Limited	0.0275p (-23.61%)	2.06B
NTVONativo Resources Plc	0.0019p (0.00%)	1.06B
TRPTower Resources Plc	0.031p (-4.62%)	750.67M
SYMESupply@me Capital Plc	0.0039p (16.42%)	550.3M
QBTQuantum Blockchain Technologies Plc	1.625p (124.14%)	460.21M